Achieve Life Sciences
ACHV
61 hedge funds and large institutions have $57.8M invested in Achieve Life Sciences in 2013 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 8 closing their positions.
113% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 8
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
5% more funds holding
Funds holding: 58 → 61 (+3)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
16% less capital invested
Capital invested by funds: $68.8M → $57.8M (-$11.1M)
47% less call options, than puts
Call options by funds: $322K | Put options by funds: $610K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$1.67M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.56M |
| 3 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
+$1.3M |
| 4 |
VAM
Visium Asset Management
New York
|
+$1.23M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$895K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$7.08M |
| 2 |
QF
QVT Financial
New York
|
-$3.71M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$2.45M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$1.15M |
| 5 |
JGC
J. Goldman & Co
New York
|
-$811K |
ACHV Hedge Fund Activity: Q4 2013 in Review
61 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q4 2013, worth a combined $57.8M — down 16% from $68.8M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new ACHV positions and 8 closed out — a net gain of 4 holders — while 17 added to existing stakes and 8 trimmed.
The largest buyer was BlackRock Advisors, adding an estimated $1.67M. The largest seller was RA Capital Management, exiting entirely with an estimated $7.08M sold.
- 61 institutional investors held Achieve Life Sciences (ACHV) as of Q4 2013, up from 58 in Q3 2013.
- Funds reported $57.8M of Achieve Life Sciences stock for Q4 2013, down 16% quarter-over-quarter.
- 12 funds opened new Achieve Life Sciences positions in Q4 2013 and 8 closed out, a net change of +4 holders.
- The largest Achieve Life Sciences buyer in Q4 2013 was BlackRock Advisors, an estimated $1.67M added.
- The largest Achieve Life Sciences seller in Q4 2013 was RA Capital Management, an estimated $7.08M sold.
Based on aggregated 13F filings for Q4 2013.